Molecular-Genetic Profiling of NPM1-Mutated Acute Myeloid Leukemia and Its Prognostic Value

被引：0
|
作者：
Motyko, Ekaterina [1 ]
Kirienko, Anna [1 ]
Kustova, Daria [1 ]
Gert, Tatiana [1 ]
Leppyanen, Irina [1 ]
Radjabova, Asiyat [1 ]
Karyagina, Elena [2 ]
Ukrainchenko, Ekaterina [3 ]
Zyuzgin, Ilya [4 ]
Sidorkevich, Sergey [1 ]
Martynkevich, Irina [1 ]
机构：
[1] Russian Res Inst Hematol & Transfusiol, St Petersburg, Russia
[2] Municipal Clin Hosp 15, St Petersburg, Russia
[3] St Petersburg State Budgetary Healthcare Inst Al, St Petersburg, Russia
[4] NMRC Oncol, St Petersburg, Russia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
AML; NPM1; next-generation sequencing; acute myeloid leukemia; prognosis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-379
引用
收藏
页码：S311 / S311
页数：1
相关论文
共 50 条
  • [41] Clinicopathologic and Genetic Characterization of non-AML NPM1-Mutated Myeloid Neoplasms
    Patel, Sanjay
    Ho, Caleb
    Sadigh, Sam
    Bagg, Adam
    Geyer, Julia
    Xu, Mina
    Mason, Emily
    Morgan, Elizabeth
    Steensma, David
    Winer, Eric
    Hasserjian, Robert
    Weinberg, Olga
    LABORATORY INVESTIGATION, 2019, 99
  • [42] Clinicopathologic and Genetic Characterization of non-AML NPM1-Mutated Myeloid Neoplasms
    Patel, Sanjay
    Ho, Caleb
    Sadigh, Sam
    Bagg, Adam
    Geyer, Julia
    Xu, Mina
    Mason, Emily
    Morgan, Elizabeth
    Steensma, David
    Winer, Eric
    Hasserjian, Robert
    Weinberg, Olga
    MODERN PATHOLOGY, 2019, 32
  • [43] Clonal Hematopoiesis and Its Implications for Flow Cytometric Assessment of Measurable Residual Disease in Patients with NPM1-mutated Acute Myeloid Leukemia
    Loghavi, Sanam
    DiNardo, Courtney D.
    Takahashi, Koichi
    Kanagal-Shamanna, Rashmi
    Tanaka, Tomoyuki
    Furudate, Ken
    Short, Nicholas J.
    Kadia, Tapan M.
    Konopleva, Marina
    Farnoud, Noushin
    Pierce, Sherry A.
    Khoury, Joseph D.
    Jorgensen, Jeffrey L.
    Patel, Keyur P.
    Medeiros, L. Jeffrey
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Wang, Sa A.
    BLOOD, 2020, 136
  • [44] Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia
    Carbonell, Diego
    Suarez-Gonzalez, Julia
    Chicano, Maria
    Andres-Zayas, Cristina
    Diez-Diez, Miriam
    Rodriguez-Macias, Gabriela
    Muniz, Paula
    Kwon, Mi
    Anguita, Javier
    Diez-Martin, Jose Luis
    Buno, Ismael
    Martinez-Laperche, Carolina
    LEUKEMIA & LYMPHOMA, 2021, 62 (05) : 1178 - 1186
  • [45] Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
    Kroenke, Jan
    Schlenk, Richard F.
    Jensen, Kai-Ole
    Tschuertz, Florian
    Corbacioglu, Andrea
    Gaidzik, Verena I.
    Paschka, Peter
    Onken, Shiva
    Eiwen, Karina
    Habdank, Marianne
    Spaeth, Daniela
    Luebbert, Michael
    Wattad, Mohammed
    Kindler, Thomas
    Salih, Helmut R.
    Held, Gerhard
    Nachbaur, David
    von Lilienfeld-Toal, Marie
    Germing, Ulrich
    Haase, Detlef
    Mergenthaler, Hans-Guenther
    Krauter, Juergen
    Ganser, Arnold
    Goehring, Gudrun
    Schlegelberger, Brigitte
    Doehner, Hartmut
    Doehner, Konstanze
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (19) : 2709 - 2716
  • [46] NPM1-mutated myeloid neoplasm with low percentage of blasts
    Falini, Brunangelo
    Chiusolo, Patrizia
    Fianchi, Luana
    Pagano, Livio
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (08) : 1599 - 1600
  • [47] A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure
    Sartor, C.
    Brunetti, L.
    Audisio, E.
    Cignetti, A.
    Zannoni, L.
    Cristiano, G.
    Nanni, J.
    Ciruolo, R.
    Zingarelli, F.
    Ottaviani, E.
    Patuelli, A.
    Bandini, L.
    Forte, D.
    Sciabolacci, S.
    Cardinali, V.
    Papayannidis, C.
    Cavo, M.
    Martelli, M. P.
    Curti, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, : 599 - 607
  • [48] Characterization of NPM1-Mutated/FLT3 ITD-negative acute myeloid leukemia with normal karyotype by gene expression profiling.
    Bullinger, Lars
    Dohner, Konstanze
    Kranz, Raphael
    Rucker, Frank G.
    Frohling, Stefan
    Schlenk, Richard F.
    Pollack, Jonathan R.
    Dohner, Hartmut
    BLOOD, 2006, 108 (11) : 50A - 50A
  • [49] Measurable residual disease detected by flow cytometry independently predicts prognoses of NPM1-mutated acute myeloid leukemia
    Zhang, Yun-Wei
    Su, Long
    Tan, Ye-Hui
    Lin, Hai
    Liu, Xiao-Liang
    Liu, Qiu-Ju
    Sun, Jing-Nan
    Zhang, Ming
    Du, Ya-Zhe
    Song, Fei
    Han, Wei
    Gao, Su-Jun
    ANNALS OF HEMATOLOGY, 2023, 102 (02) : 337 - 347
  • [50] Mutational spectrum of de novo NPM1-mutated acute myeloid leukemia patients older than 75 years
    Pettersson, Louise
    Holmgren, Benjamin
    Juliusson, Gunnar
    Lazarevic, Vladimir Lj
    Ehinger, Mats
    LEUKEMIA & LYMPHOMA, 2021, 62 (08) : 1958 - 1966
12345